The French startup Bioptimus launches H-optimus-0 artificial intelligence model. It has been trained on hundreds of millions of images and will help diagnose diseases. This was reported by Bloomberg.
The model is capable of performing complex tasks, including identifying cancer cells and detecting genetic abnormalities in tumors. Bioptimus describes the system as the largest open-source and widely available model for diagnosing pathologies.
Bioptimus CTO Rodolphe Jenatton said that the company chose the open source model to ensure transparency in the field and accelerate development. He also called the appearance of H-optimus-0 “part of the longer journey.”
Bioptimus was founded in February with the support and investment of French biotechnology company Owkin Inc. The startup has received $35 million in seed funding from investors including Sofinnova Partners, state investment bank Bpifrance, and telecommunications billionaire Xavier Niel.
The French startup is one of many firms trying to apply artificial intelligence to medical breakthroughs. Google's DeepMind recently released a new version of AlphaFold, an artificial intelligence system designed to predict the structure of proteins.